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s u m m a r y
This study was part of a larger cross-sectional survey that was evaluating tuberculosis (TB) infection in
humans, livestock and wildlife in the Serengeti ecosystem in Tanzania. The study aimed at evaluating the
genetic diversity ofMycobacterium tuberculosis isolates from TB patients attending health facilities in the
Serengeti ecosystem. DNAwas extracted from 214 sputum cultures obtained from consecutively enrolled
newly diagnosed untreated TB patients aged 18 years. Spacer oligonucleotide typing (spoligotyping)
and Mycobacterium Interspersed Repetitive Units and Variable Number Tandem Repeat (MIRU-VNTR)
were used to genotype M. tuberculosis to establish the circulating lineages. Of the214 M. tuberculosis
isolates genotyped, 55 (25.7%) belonged to the Central Asian (CAS) family, 52 (24.3%) were T family (an
ill-deﬁned family), 38 (17.8%) belonged to the Latin American Mediterranean (LAM) family, 25 (11.7%) to
the East-African Indian (EAI) family, 25 (11.7%) comprised of different unassigned (‘Serengeti’) strain
families, while 8 (3.7%) belonged to the Beijing family. A minority group that included Haarlem, X, U and
S altogether accounted for 11 (5.2%) of all genotypes. MIRU-VNTR typing produced diverse patterns
within and between families indicative of unlinked transmission chains. We conclude that, in the
Serengeti ecosystem only a few successful families predominate namely CAS, T, LAM and EAI families.
Other types found in lower prevalence are Beijing, Haarlem, X, S and MANU. The Haarlem, EAI_Somalia,
LAM3 and S/convergent and X2 subfamilies found in this study were not reported in previous studies in
Tanzania.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Background
Tuberculosis (TB) caused byMycobacterium tuberculosis (Mtb) is
the second major cause of death from infectious diseases world-
wide [1]. Over the last two decades, molecular typingmethods such
as IS6110-RFLP [2], spoligotyping [3] and MIRU-VNTR [4] have been
applied and have revolutionised our understanding of the epide-
miology of TB, by providing novel insights into the genetic diversity
and population structure of M. tuberculosis complex (MTBC) [5].
Epidemiological data generated through genotyping has been used
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extensively to further the understanding of TB disease dynamics
[6]. For example, at the individual level, cases of recurrence or
treatment failure can be explained in terms of reactivation of the
same strain, exogenous re-infection or due to polyclonal infection
[7]. At a population level, the origins and transmission dynamics of
outbreaks can be determined [8e10]; while at global level, TB
genotypic lineages have been deﬁned and used to monitor their
geographical distribution and spread [6]. A crucial aspect of any TB
control program is the ability to quantify the contribution of
transmission in order to inform policy makers to direct resources to
identify infectious cases to prevent further spread of infection as
well as to implement preventative therapy for thosewho have been
infected (children and HIV positive individuals). The CAS family of
M. tuberculosis strains are dominant in Tanzania [11e13] with little
variations over time period [14,15] with some anti-tuberculosis
drug resistance and multidrug resistance [15]. Although these
previous studies have been carried in northern Tanzania (4) and
Dar es Salaam (1) none has targeted the Serengeti ecosystem and
the earlier studies focused largely on TB and its association with
HIV/AIDS. However, one cannot conclude that every location in
Tanzania is represented by this earlier data which therefore pro-
vides a justiﬁcation for studies in new locations, where ﬁndings
might potentially provide data that could inﬂuence TB control
strategies in the country.
In this study we used molecular epidemiological tools to
describe the genetic diversity of mycobacteria in the Serengeti
ecosystem where humans, livestock and wildlife are in close con-
tact with the possibility of cross-transmission [16]. Speciﬁcally, the
genotyping was achieved using spoligotyping and MIRU-VNTR
typing methods. We report on the genetic diversity of M. tubercu-
losis isolated from tuberculosis patients resident in three sub-
districts of the Serengeti ecosystem.
2. Materials and methods
2.1. Study design and settings
This cross-sectional study was conducted in focal health facil-
ities serving three districts of Bunda, Ngorongoro and Mugumu-
Serengeti in the Serengeti ecosystem where TB screening is done
regularly (Figure 1). The population densities for the three districts
according to Tanzanian population statistics (2013) are Bunda
(108.3 persons/km2), Serengeti (22.4 persons/km2) and Ngorongoro
(11.2 persons/km2) with unpublished and limited information on
the incidences of TB and HIV in these areas. These centres included
District Designated Hospitals (DDH) in Bunda, Serengeti
(Mugumu), Ngorongoro (Waso) and Endulen (in the Ngorongoro
Conservation Area). The Bunda District Designated Hospital (DDH)
Figure 1. Map of the Serengeti ecosystem comprising of the Serengeti National Park, Ngorongoro Conservation Area, Ikorongo-Grumeti Game Reserves, Maswa Game Reserve. The
District Designated Hospitals and Health Centres are indicated by arrows and marked by letters A: Endulen Heath Centre; B: Bunda DDH; C: Mugumu DDH; D: Waso DDH.
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provides health services to nearby villages of neighbouring dis-
tricts, such as Magu district (Lamadi village very close to Bunda) of
Mwanza alongside the Serengeti National Park, some villages of
Musoma district and other nearby districts of the Mara region. All
patients with symptoms suggestive of TB presenting at these fa-
cilities during the study period (October 2010eNovember 2012)
were eligible for the study. Only patients who gave written
informed and signed consent forms were enrolled in the study.
2.2. Sample collection
Sputum samples from self-reporting TB suspects were consec-
utively collected in transport medium, cetyl-pyridinium chloride
(CPC) [17] from October 2010 to November 2012. A total of 472
sputum samples were collected from individuals presenting with
TB symptoms. The sputum smears were Ziehl Neelsen-stained and
examined microscopically for acid-fast bacilli (AFB) at the health
centres. Two hundred and thirty-seven (237, 50.2%) were AFB
smear-positive. All sputum samples were then transported in cetyl-
pyridinium chloride (CPC) to the Central TB Reference Laboratory
(CTRL) in Dar es Salaam for mycobacterial culture within 7 days of
collection.
2.3. Sputum sample processing
During sample processing, the sputum-CPC mixture was
concentrated by centrifuging at 4000 rpm for 15 min. The super-
natants were poured off into a splash proof container. Twenty
millilitres (20 ml) of sterile distilled water was added to the sedi-
ments and the pellets were suspended by inverting the tubes
several times, and then centrifuged at 3500 rpm for 15 min. The
supernatant was removed; the pellets were used for culture. On
culture 214 (out of 237 sputa, 90.3%) yielded M. tuberculosis colony
growths which were available for DNA extraction and subsequent
molecular analysis.
2.4. Culture and identiﬁcation
Two L€owenstein-Jensen slants, one containing 0.75% glycerol
and the other 0.6% pyruvate were inoculated with the sediments
and incubated at 37 C and growth examined weekly for 8 weeks
whereby cultures with no growth after eight weeks were consid-
ered negative.
2.4.1. DNA extraction procedures
Extraction of mycobacterial DNA was performed by boiling a
loop full of bacteria in 100 mL H2O at 80 C for 60 min. Crude DNA
extracts were stored at20 C until when spoligotyping andMIRU-
VNTR typing were performed.
2.5. Spoligotyping
A commercially available spoligotyping kit (Isogen, Bioscience
BV, Maarssen, The Netherlands) was used for spoligotyping as
previously described by Kamerbeek et al. [3]. This PCR-based
ﬁngerprinting method detects the presence or absence of 43 vari-
able spacer sequences situated between short direct repeat (DR)
sequences in the M. tuberculosis genome. The DNA from reference
M. tuberculosis H37Rv and Mycobacterium bovis BCG clones were
used as positive controls while autoclaved ultrapure water was
used as a negative control. Visualization of presence (black squares)
or absence (blank squares) of variable spacer sequences on ﬁlmwas
achieved after incubation with streptavidin-peroxidase and
detection of hybridized DNA using enhanced chemiluminescent
ECL (Amersham, Little Chalfont, United Kingdom) detection liquid
followed by exposure to X-ray ﬁlm (Hyperﬁlm ECL; Amersham) as
per manufacturer's instructions (GE Healthcare Life Sciences).
Resulting spoligotypes were reported in octal and binary formats
(Table 3) and compared to existing patterns in an international
spoligotyping database proﬁles (SpolDB4.0) [18] available at http://
www.pasteur-guadeloupe.fr:8081/SITVITDemo/. Spoligotype pat-
terns were grouped as spoligotype international types (SITs) if they
shared identical spoligotype patterns with patterns present in the
existing database. In previous studies, isolates which could not be
assigned to speciﬁc SITs were referred to as orphans [19e21]; in our
study we decided to name the isolates with no SITs assigned as
‘Serengeti strains’. Spoligotype families were assigned as previously
described [18,22].
2.6. MIRU-VNTR typing
The standardized 24 loci MIRU-VNTR typing protocol by Supply
et al. [23]was followed using primers that amplify 24 polymorphic
loci on the mycobacterial genome per DNA isolate. All Beijing ge-
notype isolates and a selection of isolates representing the spoli-
gotype EAI5, CAS1_Kili, CAS1_DELHI and LAM11_ZWE families
were genotyped using this method. In brief, 2 ml of mycobacterial
DNAwas added to a ﬁnal volume of 25 ml containing 8.375 ml of free
RNase water (Qiagen, USA), 5 ml of Q solution, 2.5 ml of 10x buffer,
2 ml of 1.5 mMMgCl2 (Roche, USA), 4 ml of 0.2 mM dNTPs (Promega,
WI USA), 1 ml primer and 0.125 ml of HotStar Taq polymerase (1U).
The PCR conditions included three stages: initial denaturation at
95 C for 15 min (Stage 1), second denaturation at 94 C for 1 min,
annealing at 62 C for 1 min, initial extension for 1 min at
72 C(Stage 2) and ﬁnal extension at 72 C for 10 min followed by
cooling to 4 C prior to analysis (Stage 3). A 45-cycles PCR was done
on Veriti™ 96-well Thermal Cycler (Applied Bio system, Singapore).
The laboratory M. tuberculosis H37Rv reference strain DNA was
used as positive control and DNA-free water as a negative control.
Ampliﬁcation products were electrophoretically fractionated in 1%
agarose gel (SeaKem® LE) in 1x SPE buffer at 160 V for 4 h to allow
maximum fragment size separation for clear discrimination. The
number of tandem repeat units present at each locus was calcu-
lated from the size of DNA fragments according to a standardized
table (http://www.MIRU-VNTRplus.org). The results were
expressed in digital format where each number represented the
number of repeat copies at a particular locus. Phylogenetic analysis
and creation of dendograms was done using MIRU-VNTRplus
(http://www.MIRU-VNTRPlus.org/) to generate a categorical based
NJ-Tree dendrogram to enable comparison of strain genotypes
within the study area [24,25] in an attempt to establish trans-
mission links.
Table 1
Distribution of various M. tuberculosis families based on spoligotype pattern by
district (n ¼ 214).
SITs Ngorongoro Serengeti Bunda Total %
CAS 33 11 11 55 25.7
T 14 17 21 52 24.3
LAM 18 6 14 38 17.8
EAI 6 5 14 25 11.7
Beijing 1 4 3 8 3.7
Haarlem 3 3 0 6 2.8
X 1 0 0 1 0.5
U 0 1 1 2 0.9
S 0 0 1 1 0.5
MANU 1 0 0 1 0.5
Serengeti 15 0 10 25 11.7
Total 93 46 75 214 100.0
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3. Results
3.1. Mycobacterial cultures
During the study period sputum samples were collected from
472 individuals presentingwith TB symptoms. Of these, 237 (50.2%)
were smear-positive and when cultured 214 grew M. tuberculosis
on LJ media, with colonies that provided DNA which was available
for genotyping.
3.2. Spoligotyping and distribution of spoligotypes by district
As shown in Table 1, 88.3% (189 out of 214 isolates) of the spo-
ligotypes could be grouped into 9 known spoligotype families,
while 25 (11.7%) were ‘Serengeti strains’. The Serengeti type strains
resemble the CAS strain family, but have not previously been re-
ported in SpolDB4. The Central Asian Strain family (CAS) accounted
for 25.7% (n¼ 55) of all isolates followed by an ill-deﬁned (T) family
that accounted for 52 (24.3%) isolates. The Latin American Medi-
terranean (LAM) family accounted for 38 (17.8%) isolates while the
East African-Indian family accounted for 25 (11.7%) isolates. Eight
(3.7%) isolates belonged to the Beijing family. The rest of the fam-
ilies were minor and comprised of Haarlem (8, 2.8%), X (1, 0.5%), U
(0.9%), S (1, 0.5%) and MANU (1, 0.5%). Breakdown of spoligotypes
by districts (Table 1) indicated 33 (60%) of the CAS family over-
represented in Ngorongoro with Serengeti and Bunda districts ac-
counting for 11 (20%) of the strain type each. A relatively high
proportion (40.4%) of T family strains was found in Bunda district
compared to Serengeti (32.7%) and Ngorongoro (26.9%). As regards
the LAM family, nearly half (47.4%) of the strains in this family were
found in Ngorongoro, followed by Bunda (36.8%) and Serengeti
(15.8%). The rest of the strains found in small proportions were
considered minor (Table 1). However, the high number for Bunda
could be explained by the relatively larger sample size (almost
double, that of Serengeti). The distribution of strain families by
district is reﬂected in Table 1 and the ﬁner categorization into
subfamilies is presented in Table 2.
3.3. Distribution of strain subfamilies
Comparisons at district levels were more convenient to address
spatial dominance of these subfamilies, considering the differences
in sample sizes by districts. Assignment of spoligotype patterns to
families revealed the CAS1_Kili subfamily to be predominant
constituting 17.8% (38/214) of all spoligotype patterns (Table 2).
Most of the CAS1_Kili strains were found in Ngorongoro (68.4%, 26/
34) followed by Bunda (23.7%, 9/38) and Serengeti (7.9%, 3/38). The
LAM11_ZWE strains were the second most dominant (13.6%, 29/
214), with highest proportions in Bunda (41.4%) followed by
Ngorongoro (37.9%) and then Serengeti (20.7%). These dominant
subfamilies were followed by the T1 family (10.7%), EAI5 (9.3%),
CAS1_DELHI (6.5%), T2 (5.6%), T3_ETH (5.1%), Beijing (3.7%) and
LAM9 (3.3%). Other subfamilies were variably found in smaller
proportions and included in this groupwere the EAI5 or EAI3 (1.9%),
H3 (1.4%), T2-Uganda (1.4%), H1 (0.9%), CAS (0.9%), T3 (0.9%) and
other strains (Table 2). Among the strains that found to be in small
proportions, the Haarlem (2.8%), EAI_Somalia (0.5%), LAM3 and S/
convergent (0.5%) and X2 (0.5%) subfamilies were not reported in
previous studies in Tanzania. About 11.7% of our isolates were
‘Serengeti strains’. Representative isolates indicating strain family
(or clades), SITs, their octal codes and the webdings format for
absence or presence of speciﬁc spacers along the DR (direct repeat)
region of the M. tuberculosis gene are shown in Table 3.
3.4. MIRU-VNTR typing and phylogenetics
Phylogenetic relationship between subfamilies indicative of
dynamics of transmission from standard 24-loci MIRU-VNTR typing
of selected few isolates is presented in a dendrogram (Figure 2). The
standard 24-loci MIRU-VNTR tying results were compared with
their respective spoligotyping results (Table 4). The MIRU-VNTR
typing patterns of polymorphisms at different loci along the
mycobacterial genome are clearly reﬂected. While spoligotype
patterns constituting the same family are largely identical, the
MIRU-VNTR patterns often differed in at least one locus. Most
related families and subfamilies had identical patterns of poly-
morphisms within families and sub-families, respectively. Vari-
ability in polymorphisms was observed among the isolates
656_Beijing_Bunda and 588_CAS1_Kili_Bunda which differed in
patterns from their corresponding clades (see also Figure 2). The
Beijing family (656 from Bunda) differed from other members of
the family in at least 6 loci (Table 4). This strain also differed in
patterns from other Beijing strain isolates within Bunda (isolates
No. 724, 725) as is also reﬂected in the phylogenetic dendrogram
(Figure 2). The CAS1_DELHI from Ngorongoro (N1367) was also
different in MIRU-VNTR typing patterns from that from Serengeti
(255). The MIRU-VNTR typing showed the CAS1_Kili strains from
Serengeti and Ngorongoro to have matching patterns (Table 4)
(Figure 2)
4. Discussion
4.1. Spoligotyping and strain proﬁle
The main circulating M. tuberculosis strains in the Serengeti
ecosystem appear to be the CAS, T, LAM and the EAI genotypes in
that order. These four strain families accounted for 79.4% of all
genotypes, while all other named families; Beijing, Haarlem, X, U, S,
MANU, accounted for only 8.9% of all genotypes. A signiﬁcant
Table 2
Distribution of spoligotype patterns of subfamilies in the three districts in the
Serengeti ecosystem.
Sub-family Ngorongoro Serengeti Bunda Total %
BEIJING 1 4 3 8 3.7
CAS 2 0 0 2 0.9
CAS1_DELHI 5 8 1 14 6.5
CAS1_KILI 26 3 9 38 17.8
CAS2 0 0 1 1 0.5
EAI1_SOM 1 0 0 1 0.5
EAI5 4 4 12 20 9.3
EAI5 or EAI3 1 1 2 4 1.9
H1 2 0 0 2 0.9
H3 0 3 0 3 1.4
H3-T3 1 0 0 1 0.5
LAM11_ZWE 11 6 12 29 13.6
LAM3 and S/convergent 1 0 0 1 0.5
LAM6 1 0 0 1 0.5
LAM9 5 0 2 7 3.3
MANU2 1 0 0 1 0.5
S 0 0 1 1 0.5
T1 8 3 12 23 10.7
T2 0 12 0 12 5.6
T2-T3 1 0 0 1 0.5
T2-Uganda 0 0 3 3 1.4
T3 0 0 2 2 0.9
T3_ETH 5 2 4 11 5.1
U 0 1 1 2 0.9
X2 1 0 0 1 0.5
Serengeti 15 0 10 25 11.7
Total 93 46 75 214 100.0
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Table 3
Representative M. tuberculosis families as was detected by spoligotyping in this study. SITs ¼ spoligotype international types; * ¼ families with no (un-assigned) SITS. Black
squares and white squares represent the presence and absence of speciﬁc spacer along positions 1 to 43 in the DR locus, respectively. AllM. tuberculosis isolates were obtained
from human subjects.
S/N Family (clades) SITs Octal code No. of strains % Spoligotype pattern Host
1 BEIJING 1 000000000003771 08 3.7 Human
2 CAS1_KILI 21 703377400001771 38 17.8 Human
3 CAS 2269 703777740001771 02 0.9 Human
4 CAS1_DELHI 26 703777740003771 14 6.5 Human
5 CAS2 288 700377740003771 01 0.5 Human
6 EAI5 126 477777777413671 20 9.3 Human
7 EAI5 or EAI3 8 400037777413771 04 1.9 Human
8 EAI1_SOM 1801 777777777413731 01 0.5 Human
9 LAM11_ZWE 2196 777777606060771 29 13.6 Human
10 LAM6 64 777777607560771 01 0.5 Human
11 LAM9 42 777777607760771 07 3.3 Human
12 LAM3 and
s/convergent
4 000000007760771 01 0.5 Human
13 H1 727 777737774020731 02 0.9 Human
14 H3 50 777777777720771 03 1.4 Human
15 H3-T3 36 777737777720771 01 0.5 Human
16 MANU2 1192 777777677763771 01 0.5 Human
17 S 34 776377777760771 01 0.5 Human
18 T1 53 777777777760771 23 10.7 Human
19 T2 135 777777777760730 12 5.6 Human
20 T2-T3 73 777737777720771 01 0.5 Human
21 T3 37 777737777760771 02 0.9 Human
22 T3_ETH 345 777000377760771 11 5.1 Human
23 T2-Uganda 437774777760730 03 1.4 Human
24 U 458 777777607740771 02 0.9 Human
25 X2 137 777776777760601 01 0.5 Human
26 Serengeti no SITs 703377400000771 25 11.7 Human*
214 100
Figure 2. A NJ-Tree dendrogram of 18 representative samples from MIRU-VNTR typing showing relationships among families. The categorical based NJ-phylogenetic tree was
generated from MIRU-VNTRPlus-24 (http://www.miru-vntrplus.org/). Selected strains were used from each constituent site in the ecosystem to assess whether there was a deﬁned
transmission link for the circulating strains in the ecosystem.
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percentage (11.7%) of our strains could not be linked to any known
spoligotype and were therefore designated as ‘Serengeti strains’.
The predominance of the four families seen in our study is
comparable with the ﬁndings of similar studies done in Kilimanjaro
and Dar es Salaam, but with some differences [14,15]. Members of
these families, though not in the same dominance order, have also
been reported in countries neighbouring Tanzania [15], such as
Ethiopia [19,26], Zambia [20] and Uganda [27e29], indicating that
they are widespread in this region.
A comparison of our study ﬁndings with the other two studies
previously conducted in Tanzania is shown in Table 5. The major
difference between our study and the previous two studies done in
Tanzania is that we found 6 (2.8%) isolates belonging to the Haar-
lem family while the other previous studies [14,15] did not ﬁnd
members of this genotype. In addition, the study by Kibiki et al. [15]
did not report X and S families, while that by Eldholm et al. [14] did
not report any MANU strain family. Among strain families not
previously reported in Tanzania also included, EAI_Somalia, LAM3
and S/convergent and X2 subfamilies (Table 2). This study also
found higher proportion of T family strains than the other two
previous studies. The ﬁnding of 11.7% of genotypes with no SITs in
the international spoligotype database [18] is interesting, possibly
reﬂecting micro evolutionary events in the DR region of an existing
strain [6,14,15,20,30]. The new strains (named ‘Serengeti strains’ in
this study) appear to be relatively prevalent in Ngorongoro and
Bunda but not in Serengeti. This variant is possibly a CAS1- Kili
relative. CAS1-Kili is characterised by the absence of spacers 4e7,10
and 20e35, whereas the Serengeti strains have additionally lost
spacer 36.
Our study found some differences in the distribution of strains
by districts. For example, while the T family is relatively uniformly
distributed among the three districts, the CAS family predominated
in Ngorongoro while EIA was highest in Bunda district. Further-
more, the lowest proportion of Beijing family was found in Ngor-
ongoro compared to high proportions that were found in Serengeti
and Bunda districts (Table 1). Other families were conﬁned to single
districts e.g. X strains were found only in Ngorongoro, S in Bunda
and MANU in Ngorongoro. Comparisons of genotyping results and
study sites for previous and current studies conducted in Tanzania
are shown in Table 5 and Figure 3, respectively.
Further analysis (at subfamily level) of the isolates revealed the
CAS1_Kili and LAM_ZWE subfamilies to be predominant in Ngor-
ongoro, T2 and CAS1_DELHI in Serengeti and EA15 and
LAM11_ZWE in Bunda (Table 2). The predominance of various
strain families and subfamilies in different districts could be due to
geographical isolation. CAS1_Kili for example, is believed to have
emerged from the Horn of Africa, and is capable of diversifying into
multiple genotypes [31]; together with other members in the CAS
family they constitute the modern strains which include genetic
group 1 strains belonging to the East Asian lineage (lineage 2) or to
the East-African Indian lineage (lineage 3) [32]. In addition, the
CAS1_Kili strain has been reported to be the dominant circulating
strain in Tanzania [14,15]. It is without doubt that the CAS1_Kili has
been successful in this region and as a clone it might be evolving
independently acquiring genetic diversity over a long period of
time thus having a high transmission level of its conserved circu-
lating clones [33]. This could be responsible for the dominance of
the CAS1_Kili family (68.4% of all CAS family) in the Ngorongoro
district. We also observed variability in strain predominance with
district which can be explained by differences in the characteristics
of populations among the three districts. Bunda for example, is a
town centre linking people in movement from various places, as
such, the area is predisposed to possible introduction of potentially
new strains notable in form of Beijing (varying strains of, Figure 2),
S and T2-Uganda (Table 2). The changes in family strain composi-
tion in the population has been said to be attributable to increased
in and out migration as well as travel across regions thus increasing
chances for exposure to different strains [34]. The variability in
predominance of strains in this study reﬂects that the Serengeti
ecosystem contains a diverse group ofM. tuberculosis strains which
Table 4
Combined typing results of 24-loci MIRU-VNTR and spoligotyping analysis of 18 representative Mycobacterium tuberculosis isolates from the Serenegti ecosystem.
SN Isolate Origin Family MIRU-VNTR (std 24-loci) Spoligotype patterns
1 656 Bunda Beijing 223325163633424563544432
2 705 Serengeti Beijing 224325173533423463444433
3 710 Serengeti Beijing 224325163533423463444433
4 700 Serengeti Beijing 223325163533423463444433
5 697 Serengeti Beijing 223325163533423463344433
6 N1254 Ngorongoro Beijing 223325171531424553444433
7 724 Bunda Beijing 223335171531424553444433
8 725 Bunda Beijing 224325171741424553544432
9 703 Serengeti CAS1_Kili 229325113344524522524235
10 481 Ngorongoro CAS1_Kili 229325113344524322544235
11 588 Bunda CAS1_Kili 223525113344524322524235
12 255 Serengeti CAS1_DELHI 223525173423724524524455
13 N1367 Ngorongoro CAS1_DELHI 226525123733723523524235
14 677 Serengeti EAI5 245327223523642644643131
15 B732 Bunda EAI5 245327223523642534643131
16 068 Ngorongoro LAM11_ZWE 225525113324224322224253
17 374 Bunda LAM11_ZWE 225126141322214342244153
18 264 Serengeti LAM11_ZWE 225126152321312332244153
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could have implications in devising TB control strategies. This is
because the ﬁndings reﬂect potential for different sources of
infection which could determine the type of strategy for effective
control of the disease to restrain the potentially different trans-
mission chains. This is particularly important in cases where they
have different degrees of resistance against anti-tuberculosis drugs.
4.2. MIRU-VNTR typing and phylogenetics
In our study the dendrogram (Figure 2) from selected repre-
sentative isolates that included Beijing, EAI5, CAS1_Kili, CAS1_-
DELHI and LAM11_ZWE showed that some of the families had
identical patterns of polymorphisms located in proximity to each
other in the dendrogram. The few exceptions were the 656_Bei-
jing_Bunda and 588_CAS_Kili_Bunda that had different patterns
from their corresponding clades indicative of different strains that
may be new. This underlines the fact that while spoligotyping can
provide rapid identiﬁcation and group spoligotype patterns ac-
cording to families, MIRU-VNTR typing can ﬁnely discriminate
strains within and between families and subfamilies as well as
establishing transmission links [20,23]. In this study, the results
from MIRU-VNTR typing revealed difference in polymorphisms in
at least one locuswith resultant different patternswithin the family
as was observed in one of the Beijing families (656 fromBunda) that
variably differed from other members of the family in 6 loci
(similarly for other Beijing strains isolated within Bunda (isolates
No. 724, 725)). The results however, showed the Beijing strains in
Ngorongoro to be closely related to Beijing strains in Bunda
compared to those from Serengeti. These ﬁndings demonstrate an
Figure 3. The map of Tanzania indicating where each of the three studies was conducted. The population characteristics of the three study sites differ. While the Serengeti
ecosystem comprise of mostly pastoral communities, Dar es Salaam (Eldholm et al. study [14]) and Kilimanjaro (Kibiki et al. study [15]) are cities and townships with no pastoral
activities at all and minimal animal-human contacts. (Map Source: www.Googlemaps.com).
Table 5
Comparison of genotyping results of our study and of two previous studies con-
ducted in Tanzania.
Family Eldihom
et al., 2006 [18],*
Kibiki et al.,
2007 [19],*
Current
studyy
CAS 52 (35.4%) 49 (37.7%) 55 (25.7%)
T 21 (14.3%) 15 (11.5%) 52 (24.3%)
LAM 33 (22.4%) 31 (23.8%) 38 (17.8%)
EAI 25 (17.0%) 13 (10.0%) 25 (11.7%)
Beijing 7 (4.8%) 7 (5.4%) 8 (3.7%)
Haarlem 0 0 6 (2.8%)
X 1 (0.7%) 0 1 (0.5%)
S 3 (2.0%) 0 1 (0.5%)
MANU 0 3 (2.3%) 1 (0.5%)
Others (Orphans)z 5 (3.4%) 12 (9.2%) 25 (11.7%)
Total 147 130 214
* Only spoligotyping was done.
y Both spoligotyping and standard MIRU-VNTR were done.
z ‘Serengeti strains’ in the current study.
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absence of clustering which could be indicative of the importation
of new Beijing strains rather than transmission. MIRU-VNTR typing
also revealed the CAS1_Kili family (Table 4, Figure 2) from Serengeti
and Ngorongoro to be closer to each other while differing from that
from Bunda. This could mean that the circulating strains in Ngor-
ongoro and Serengeti for CAS1_Kili have the same chain of trans-
mission, evolution or the same recurring strain [35,36] circulating
in the area. Similarly, there were variations in polymorphisms with
the CAS1_DELHI isolate fromNgorongoro differing largelywith that
from Serengeti with polymorphisms in at least 3 loci (Table 4).
Despite the few polymorphisms in those isolates that were typed,
the EAI5 strains from Bunda and Serengeti differed at least in one
locus, and this difference could only be revealed through MIRU-
VNTR typing. Differences in patterns were also observed for the
LAM11_ZWE strains from the different districts that signiﬁcantly
differed in at least 4 polymorphic loci.
5. Conclusion
This study provides for the ﬁrst time, information on the pre-
vailing human M. tuberculosis strains at the human-
elivestockewildlife interface in the Serengeti ecosystem. Only a
few successful families (CAS, T, LAM and EAI) were abundant. The
other group of families that comprise Beijing, Haarlem, X, S and
MANU were less frequent in this study. This study reports for the
ﬁrst time Haarlem, EAI_Somalia, LAM3 and S/convergent and X2
subfamilies which were not reported in previous studies in
Tanzania.
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